QTRX: מחיר למכירות Quanterix Corp.

Quanterix Corporation is implementing Simoa technology for ultra-sensitive protein analysis, enabling early diagnosis of oncology and neurological pathologies. Effective process restructuring under experienced management has set biomarker platforms on a path of stable development. ESG principles are integrated into production through the eco-friendly disposal of reagents. The current P/S multiple reflects a market valuation where the indicator reaches 0.90.
פילוחים אנליטיים של חברת Quanterix Inc (QTRX)

For Quanterix Corporation (QTRX), which is developing the closed Simoa ecosystem with high customer switching costs, the current price-to-sales ratio reflects a market premium for the scalability of its proprietary technologies. This ratio, calculated by dividing market capitalization by annual sales volume, measures the cost per unit of revenue, allowing investors to assess whether the asset is overbought relative to the sector and the risk of overpaying amid low operating margins.